ELMD Earnings
Tuesday, May 12 2026
Revenue Estimate
$18M
Current Price
$26.39
Our Position
bullish13 straight quarters of growth, operating income up 42%
est. revisions stable
The streak shows Electromed has real operating momentum in a medical device niche, not just top-line inflation. Operating leverage is expanding faster than revenue — a sign of margin improvement and scaling efficiency as the home care business compounds.
Watch: Watch whether the new payer contracts translate into sequential revenue acceleration in Q3. Sustained operating margin expansion above 19% would confirm the business model is scaling profitably.
Data Signal Summary
0 bullish
2 bearish
Price downtrend
Insider selling
Key Context
Insider Activity
selling
Price Trend
downtrend
From 52w High
0.0%
P/E Ratio
24.7
Est. Revisions (30d)
+0.0% 1up/1dn
Analyst Target (mean)
$37 $36–$38 +40%
Options P/C Ratio
0.76
Est. Dispersion
16% 4 analysts
Fund Convergence
strong Renaissance, Two Sigma, Citadel
Recent Activity
insider trades
14 transactions
Award
·
SKARVAN KATHLEEN S (Director)
·3,000 shares
Award
·
FLUET GREGORY J (Director)
·3,000 shares
Award
·
TUNE KATHLEEN A (Director)
·3,000 shares
Award
·
ERICKSON STAN K (Director)
·3,000 shares
Award
·
WALSH ANDREA M (Director)
·3,000 shares
9 more
Award
·
GALATOWITSCH JOSEPH L
·3,000 shr
Award
·
NAGEL BRADLEY M.
·5,300 shr
Award
·
CUNNIFF JAMES L.
·17,000 shr
Sell
·
SKARVAN KATHLEEN S
·76,583 shr
·$2,334,281
Exercise
·
SKARVAN KATHLEEN S
·40,000 shr
·$72,000
Other
·
CUNNIFF JAMES L.
·87,500 shr
Sell
·
SKARVAN KATHLEEN S
·150,000 shr
·$4,201,350
Award
·
NAGEL BRADLEY M.
·5,500 shr
Award
·
CUNNIFF JAMES L.
·15,900 shr
Explore more
